Evidence map›Paper›PMID 40732362›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes.

Mohamad Suki, Johnny Amer, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Yariv Tiram, Ofer Perzon, Yousra Sharif, Joseph Sackran, Revital Alon and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mohamad SukiInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Johnny AmerInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Yael MilgromInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.ORCID 0000-0002-1749-5383
Muhammad MassarwaInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Wadi HazouInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Yariv TiramInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Ofer PerzonInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Yousra SharifInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Joseph SackranInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Revital AlonInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Nachum Emil Eliezer LourieInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Itamar RazInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.
Ashraf ImamTransplantation Unit, Department of Surgery, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.ORCID 0000-0003-0172-3844
Abed KhalailehTransplantation Unit, Department of Surgery, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.ORCID 0000-0002-4878-8189
Rifaat SafadiInstitution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cirrhosisliver outcomesMASLDmortalitysemaglutide

Identifiers

PMID40732362
PMCPMC12300756

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.